Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry combined with magnetic beads for detecting serum protein biomarkers in Parkinson's disease

European Neurology

Volumn 65, Issue 2, 2011, Pages 105-111

  Li, Yao Hua ^a   Wang, Jian ^a   Zheng, Xiao Li ^a   Zhang, Yan Li ^a   Li, Xin ^a   Yu, Shun ^a   He, Xin ^a   Chan, Piu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Biomarkers diagnosis; MALDI TOF MS; Parkinson's disease; Proteomics; Weak cationic exchange magnetic beads

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; FEMALE; HUMANS; IMMUNOMAGNETIC SEPARATION; MALE; MIDDLE AGED; PARKINSON DISEASE; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

EID: 79151478127     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323427     Document Type: Article

References (23)

1. Thomas B, Beal MF: Parkinson's disease. Hum Mol Genet 2007; 16: 183-194.
2. Fearnley JM, Lees AJ: Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-2301.
3. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
4. McGeer PL, Itagaki S, Akiyama H, McGeer EG: Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 1988; 24: 574-576.
5. McNaught KS, Olanow CW, Halliwell B, Isacson O, Jenner P: Failure of the ubiquitinproteasome system in Parkinson's disease. Nat Rev Neurosci 2001; 2: 589-594. (Pubitemid 33679832)
6. Anderson NL, Anderson NG: The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002; 1: 845-867.
7. Lin XL, Yang SY, Du J, Tian YX, Bu LN, Huo SF, Wang FP, Nan YD: Detection of lung adenocarcinoma using magnetic beads-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling. Chin Med J 2010; 123: 34-39.
8. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW: Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002; 48: 1296-1304. (Pubitemid 34809839)
9. Dotzlaw H, Schulz M, Eggert M, Neeck G: A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim Biophys Acta 2004; 1696: 121-129. (Pubitemid 38223892)
10. Kang X, Xu Y, Wu X, Liang Y, Wang C, Guo J, Wang Y, Chen M, Wu D, Wang Y, Bi S, Qiu Y, Lu P, Cheng J, Xiao B, Hu L, Gao X, Liu J, Wang Y, Song Y, Zhang L, Suo F, Chen T, Huang Z, Zhao Y, Lu H, Pan C, Tang H: Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clin Chem 2005; 51: 56-64. (Pubitemid 40024014)
11. Mian S, Ugurel S, Parkinson E, Schlenzka I, Dryden I, Lancashire L, Ball G, Creaser C, Rees R, Schadendorf D: Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients. J Clin Oncol 2005; 23: 5088-5093. (Pubitemid 46224016)
12. Breiman L, Friedman JH, Olshen RA, Stone CJ: Classification and Regression Trees. Belmont, Wadsworth, 1984.
13. Mei J, Kolbin D, Kao HT, Porton B: Protein expression profiling of postmortem brain in schizophrenia. Schizophr Res 2006; 84: 204-213.
14. Forman MS, Trojanowski JQ, Lee VM: Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 2004; 10: 1055-1063. (Pubitemid 39424865)
15. Moore DJ, West AB, Dawson VL, Dawson TM: Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 2005; 28: 57-87. (Pubitemid 41098899)
16. Twelves D, Perkins KS, Counsell C: Systematic review of incidence studies of Parkinson's disease. Mov Disord 2003; 18: 19-31. (Pubitemid 36150204)
17. Pahwa R, Lyons KE: Early diagnosis of Parkinson's disease: recommendations from diagnostic clinical guidelines. Am J Manag Care 2010; 16: 94-99.
18. Abe T, Isobe C, Murata T, Sato C, Tohgi H: Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease. Neurosci Lett 2003; 336: 105-108. (Pubitemid 36009318)
19. Gatlin-Bunai CL, Cazares LH, Cooke WE, Semmes OJ, Malyarenko DI: Optimization of MALDI-TOF-MS detection for enhanced sensitivity of affinity-captured proteins spanning a 100-kDa mass range. J Proteome Res 2007; 6: 4517-4524. (Pubitemid 350158527)
20. Zhang X, Leung SM, Morris CR, Shigenaga MK: Evaluation of a novel, integrated approach using functionalized magnetic beads, bench-top MALDI-TOF-MS with prestructured sample supports, and pattern recognition software for profiling potential biomarkers in human plasma. J Biomol Tech 2004; 15: 167-175.
21. Petricoin EF, Belluco C, Araujo RP, Liotta LA: The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat Rev Cancer 2006; 6: 961-967. (Pubitemid 44862680)
22. Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC Jr, Schraff S, Semmes OJ, Wadsworth JT, Drake RR: Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples. Laryngoscope 2008; 118: 61-68.
23. McDonald WH, Yates JR: Shotgun proteomics and biomarker discovery. Dis Markers 2002; 18: 99-105. (Pubitemid 35191664)